Squarepoint’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$153M Buy
317,208
+175,651
+124% +$46.6M 0.17% 102
2026
Q1
$15.5M Sell
141,557
-65,074
-31% -$9.27M 0.02% 831
2025
Q4
$34.4M Buy
206,631
+68,888
+50% +$11.5M 0.04% 535
2025
Q3
$27M Sell
137,743
-329,948
-71% -$54.3M 0.03% 611
2025
Q2
$42.3M Buy
467,691
+428,920
+1,106% +$33.9M 0.04% 448
2025
Q1
$2.31M Sell
38,771
-30,797
-44% -$2.85M ﹤0.01% 1981
2024
Q4
$9.21M Sell
69,568
-42,522
-38% -$3.99M 0.01% 1205
2024
Q3
$5.87M Buy
112,090
+42,464
+61% +$1.99M 0.01% 1303
2024
Q2
$4.21M Buy
69,626
+126
+0.2% +$8.74K 0.01% 1491
2024
Q1
$5.16M Buy
+69,500
New +$5.15M 0.01% 1418

Other funds holding ALAB

Squarepoint's ALAB Position: Q2 2026 in Review

Squarepoint increased its Astera Labs (ALAB) stake by 124% in Q2 2026, buying an estimated $46.6M and bringing the position to 317,208 shares worth $153M. The position accounts for 0.17% of the portfolio, ranked #102.

Squarepoint first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Squarepoint held 317,208 shares of Astera Labs worth $153M as of Q2 2026.
  • Squarepoint bought 175,651 Astera Labs shares in Q2 2026, an estimated $46.6M.
  • Astera Labs made up 0.17% of Squarepoint's portfolio in Q2 2026, its #102 holding.
  • Squarepoint first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.